Business & Finance
Drug delivery company announces total revenue increase for third quarter
Published in Clinical Trials Week, November 29th, 2004
The company reported total revenue of $28.5 million for the 3 months ended September 30, 2004, compared to $27.4 million for the third quarter of 2003. In the third quarter of 2004, product sales were $5.0 million compared to $7.7 million in 2003, and contract revenue totaled $23.6 million compared to $19.6 million in the third quarter of 2003.
The company reported a net loss of $20.5 million or $(0.24) per share for the 3 months ended September 30, 2004, compared to a net loss of $17.2 million or $(0.31) per share for the 3 months ended...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2004-11-29)
More Articles from Clinical Trials Week
- Allergy Medicine
Company gets IRB approval for phase III clinical trials for PreHistin - Anemia
Aranesp trial launched to evaluate impact of treating anemia on cardiovascular risks - Cardiovascular Disease
African American heart failure trial data submitted to the U.S. FDA - Clinical Trial
New data from hyponatremia treatment trials released - Vaccine Development
DNA vaccine aids chronic hepatitis B carrier non-responders - Adverse Drug Events
Trial aims for safer drug prescribing for institutionalized elderly - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
